Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators

Oncogene

Volumn 27, Issue 36, 2008, Pages 4909-4920

  Roue G ^a,b   Pichereau, V ^c   Lincet, H ^d   Colomer, D ^b   Sola, B ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITÉ DE CAEN   (France)

^d IFR 146 ICORE   (France)

Author keywords

Apoptotic factor; B cell lymphoma; Cyclin D1; Heat shock protein; Multiple myeloma

Indexed keywords

CHAPERONE; CYCLIN D1; CYTOKINE; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL DEATH; CELL LINE; CELL PERMEABILIZATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOID CELL; PRIORITY JOURNAL; PROTEOMICS; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CYCLIN D1; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HSP70 HEAT-SHOCK PROTEINS; IMMUNOPRECIPITATION; MICE; MOLECULAR CHAPERONES; NF-KAPPA B; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 50049115917     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.126     Document Type: Article

References (55)

1. Adams JM, Cory S. (2007). The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337.
2. Agami R, Bernards R. (2000). Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102: 55-66.
3. Alao JP. (2007). The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 6: 24.
4. Andoh T, Chock PB, Chiueh CC. (2002). The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 277: 9655-9660.
5. Beere HM. (2001). Stressed to death: regulation of apoptotic signaling pathways by the heat shock proteins. Sci STKE 2001: RE1.
6. Bertoni F, Zucca E, Cavalli F. (2004). Mantle cell lymphoma. Curr Opin Hematol 11: 411-418.
7. Bible KC, Boerner SA, Kirkland K, Anderl KL, Bartelt Jr D, Svingen PA et al. (2000). Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol. Clin Cancer Res 6: 661-670.
8. Burstein E, Duckett CS. (2003). Dying for NF-kappaB? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr Opin Cell Biol 15: 732-737.
9. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. (2006). Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31: 164-172.
10. Canman CE, Gilmer TM, Coutts SB, Kastan MB. (1995). Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9: 600-611.
11. Casanovas O, Miro F, Estanyol JM, Itarte E, Agell N, Bachs O. (2000). Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J Biol Chem 275: 35091-35097.
12. Ciocca DR, Calderwood SK. (2005). Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103.
13. Coco Martin JM, Balkenende A, Verschoor T, Lallemand F, Michalides R. (1999). Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res 59: 1134-1140.
14. Danial NN, Gramm CF, Scorrano L, Zhang CY, Krauss S, Ranger AM et al. (2003). BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424: 952-956.
15. Diehl JA. (2002). Cycling to cancer with cyclin D1. Cancer Biol Ther 1: 226-231.
16. Duquesne F, Florent M, Roue G, Troussard X, Sola B. (2001). Ectopic expression of cyclin D1 impairs the proliferation and enhances the apoptosis of a murine lymphoid cell line. Cell Death Differ 8: 51-62.
17. Ewen ME, Lamb J. (2004). The activities of cyclin D1 that drive tumorigenesis. Trends Mol Med 10: 158-162.
18. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. (2004). Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447.
19. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. (2006). Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5: 2592-2601.
20. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. (2001). Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286: 433-442.
21. Ghosh S, Karin M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl): 81-96.
22. Gotoh T, Terada K, Oyadomari S, Mori M. (2004). hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ 11: 390-402.
23. Han EK, Begemann M, Sgambato A, Soh JW, Doki Y, Xing WQ et al. (1996). Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ 7: 699-710.
24. Hengartner MO. (2000). The biochemistry of apoptosis. Nature 407: 770-776.
25. Hochhauser D, Schnieders B, Ercikan-Abali E, Gorlick R, Muise-Helmericks R, Li WW et al. (1996). Effect of cyclin D1 over-expression on drug sensitivity in a human fibrosarcoma cell line. J Natl Cancer Inst 88: 1269-1275.
26. Kamano H, Klempnauer KH. (1997). B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter. Oncogene 14: 1223-1229.
27. Kehn K, Berro R, Alhaj A, Bottazzi M, Yeh WI, Klase Z et al. (2007). Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells. Oncogene 26: 5060-5069.
28. Kornmann M, Danenberg KD, Arber N, Beger HG, Danenberg PV, Korc M. (1999). Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res 59: 3505-3511.
29. Krieger S, Grunau C, Sabbah M, Sola B. (2005). Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation. Exp Hematol 33: 652-659.
30. Kuhn DJ, Smith DM, Pross S, Whiteside TL, Dou QP. (2003). Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. J Cell Biochem 89: 824-836.
31. Lamb J, Ewen ME. (2003). Cyclin D1 and molecular chaperones: implications for tumorigenesis. Cell Cycle 2: 525-527.
32. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS et al. (2003). A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114: 323-334.
33. Le Moguen K, Lincet H, Deslandes E, Hubert-Roux M, Lange C, Poulain L et al. (2006). Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10. Proteomics 6: 5183-5192.
34. Lee KH, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG. (2005). Heat shock protein 70 negatively regulates the heat-shock-induced suppression of the IkappaB/NF-kappaB cascade by facilitating IkappaB kinase renaturation and blocking its further denaturation. Exp Cell Res 307: 276-284.
35. Liu M, Aneja R, Liu C, Sun L, Gao J, Wang H et al. (2006). Inhibition of the mitotic kinesin Eg5 up-regulates Hsp70 through the phosphatidylinositol 3-kinase/Akt pathway in multiple myeloma cells. J Biol Chem 281: 18090-18097.
36. Macario AJ, Conway de Macario E. (2007). Chaperonopathies and chaperonotherapy. FEBS Lett 581: 3681-3688.
37. Mesaeli N, Phillipson C. (2004). Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol Biol Cell 15: 1862-1870.
38. Niu MY, Menard M, Reed JC, Krajewski S, Pratt MA. (2001). Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells. Oncogene 20: 3506-3518.
39. 1 arrest in murine embryonic fibroblasts. J Biol Chem 273: 3803-3807.
40. Ortega S, Malumbres M, Barbacid M. (2002). Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87.
41. Palacios C, Gutierrez del AA, Silva A, Collins MK. (2000). The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs. Oncogene 19: 3556-3559.
42. Palacios R, Steinmetz M. (1985). Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41: 727-734.
43. Perez-Galan P, Roue G, Villamor N, Montserrat E, Campo E, Colomer D. (2006). The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107: 257-264.
44. Ruchalski K, Mao H, Li Z, Wang Z, Gillers S, Wang Y et al. (2006). Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J Biol Chem 281: 7873-7880.
45. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. (2000). Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2: 476-483.
46. Sauvageot N, Pichereau V, Louarme L, Hartke A, Auffray Y, Laplace JM. (2002). Purification, characterization and subunits identification of the diol dehydratase of Lactobacillus collinoides. Eur J Biochem 269: 5731-5737.
47. Seidl S, Kaufmann H, Drach J. (2003). New insights into the pathophysiology of multiple myeloma. Lancet Oncol 4: 557-564.
48. Sherr CJ. (1996). Cancer cell cycles. Science 274: 1672-1677.
49. Silva A, Wyllie A, Collins MK. (1997). p53 is not required for regulation of apoptosis or radioprotection by interleukin-3. Blood 89: 2717-2722.
50. Steel R, Doherty JP, Buzzard K, Clemons N, Hawkins CJ, Anderson RL. (2004). Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1. J Biol Chem 279: 51490-51499.
51. Stuart JK, Myszka DG, Joss L, Mitchell RS, McDonald SM, Xie ZH et al. (1998). Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperones. J Biol Chem 273: 22506-22514.
52. Takayama S, Bimston DN, Matsuzawa S, Freeman BC, AimeSempe C, Xie ZH et al. (1997). BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J 16: 4887-4896.
53. Wang C, Li Z, Fu M, Bouras T, Pestell RG. (2004). Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential. Cancer Treat Res 119: 217-237.
54. Yokota S, Kitahara M, Nagata K. (2000). Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res 60: 2942-2948.
55. Zahnow CA. (2002). CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res 4: 113-121.